Related Experiment Video
Updated: Oct 4, 2025
10:20
Single-cell Profiling of Developing and Mature Retinal Neurons
Published on: April 19, 2012
14.3K
Single cell transcriptomics reveals unique metabolic profiles of ependymoma subgroups
Sai Batchu1, Karan Patel2, Siyuan Yu2
1Montville, NJ, United States.
Gene
|February 10, 2022
Summary
Ependymoma subgroups show distinct metabolic profiles, revealing significant differences in metabolic pathways and contributing to tumor heterogeneity. These findings offer insights into treatment responses and potential therapeutic targets.
Area of Science:
- Oncology
- Metabolomics
- Genomics
Background:
- Ependymomas are diverse brain tumors with five main genomic subgroups.
- Intratumor heterogeneity in ependymomas remains poorly understood.
- Understanding tumor metabolism is crucial for effective treatment.
Purpose of the Study:
- To characterize the metabolic landscapes of ependymoma subgroups at the single-cell level.
- To identify metabolic pathways contributing to ependymoma heterogeneity.
- To explore potential therapeutic targets based on metabolic differences.
Main Methods:
- Computational analysis of gene expression profiles from 11,200 ependymoma single cells and 7,200 non-neoplastic cells.
- Utilized a robust workflow to assess metabolic pathway activities.
- Examined 80 metabolic pathways for differential activity across ependymoma subgroups.
Main Results:
- Metabolic profiles clustered according to ependymoma subgroups, unlike non-neoplastic cells.
- Over 75 metabolic pathways showed significant activity differences between ependymoma subgroups.
- Mitochondrial oxidative phosphorylation and drug metabolism pathways (cytochromes P450) significantly contributed to metabolic heterogeneity.
Conclusions:
- Ependymoma subgroups exhibit distinct metabolic signatures.
- Specific metabolic pathways drive intra-subgroup variation.
- Metabolic differences may explain variations in tumor behavior and treatment response, suggesting novel therapeutic strategies.
